Tyra Biosciences (NASDAQ:TYRA) Given “Outperform” Rating at Wedbush
Tyra Biosciences (NASDAQ:TYRA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Wedbush in a report released on Thursday,...
Consumer Discretionary Select Sector SPDR Fund (NYSEARCA:XLY) Share Price Crosses Above Two Hundred Day Moving Average of $170.94
Shares of Consumer Discretionary Select Sector SPDR Fund (NYSEARCA:XLY – Get Free Report) crossed above its 200-day moving average during trading on Friday . The...
Enerflex (TSE:EFX) Stock Crosses Above 200 Day Moving Average of $6.69
Shares of Enerflex Ltd. (TSE:EFX – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has...
HC Wainwright Reiterates Buy Rating for Valneva (NASDAQ:VALN)
Valneva (NASDAQ:VALN – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Thursday,...
B. Riley Lowers Viridian Therapeutics (NASDAQ:VRDN) Price Target to $25.00
Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) had its price target lowered by B. Riley from $29.00 to $25.00 in a report released on Thursday,...
HC Wainwright Comments on Alpine Immune Sciences, Inc.’s Q3 2024 Earnings (NASDAQ:ALPN)
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) – Research analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares...